Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Experts call for EU ban on diclophenic
vulture
The paper blames diclophenac for the near-extinction of vultures in Pakistan, India and Nepal in the 1990s.

Research paper warns of the risks of veterinary pharmaceuticals to wildlife

Experts are calling for an EU-wide ban on the use of diclophenac in livestock, as it is placing fragile vulture populations at risk.

According to research published in the journal Science this week, a "one health" approach is needed to address the dangers of veterinary pharmaceuticals to wildlife.

Even traces of the drug in livestock carcasses are fatal to the vultures who feed on them. Contamination of less than 1 per cent of carcasses previously led to the near extinction of three Asian species. For this reason, veterinary use of diclophenac has already been banned in many South Asian countries.

Dr Lisa Yon from the University of Nottingham's School of Veterinary Medicine, said: "It is clear from the lessons learned on the profound impact of diclofenac on vultures in India that we need to take a more integrated, 'one Health' approach to our use of VPs, and the larger impact they have on non-target species, and on the environment. 

"This is and will continue to be an issue of increasing concern for a wide variety of VPs, and one for which there needs to be greater responsibility taken across the range of stakeholders."

Last year, diclophenac was authorised for use in cattle, pigs and horses in Spain, where more than 95 per cent of the continent's vultures reside.

Spanish vultures help to control pests and disease by removing more than 8,000 tonnes of livestock caresses each year. This is estimated to save the economy €1.5 million annually.

Lead author of the research was Thijs Kuiken, professor of Comparative Pathology at the Erasmus Medical Centre. He said he was "shocked" that the drug had been authorised in Spain. "This example shows that we need to radically change the way we deal with pharmaceuticals, both those used in human and veterinary medicine."

The paper, titled "One health approach to use of veterinary pharmaceuticals", blames diclophenac for the near-extinction of vultures in Pakistan, India and Nepal in the 1990s. Veterinary diclophenac products were banned in India in 2006 and Pakistan, Nepal and Bangladesh followed suit shortly after. Experts say vulture declines have slowed or reversed in South Asia since the ban.

Co-author Martin Gilbert, a Wildlife Conservation Society vet, said the loss of vultures in South Asia was a "tragedy". He warned that unless action is taken, the situation could occur in Europe.

For the full study, visit: http://www.sciencemag.org/content/early/2014/12/03/science.1260260

Image ©Wikipedia/CC BY-SA 2.5/Thermos

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.